Media Thread, page-14435

In reply to @mrdingo and his post of IMU's CFO email ... (HotCopper reply function grrrr).

"As you know Dingo, here at IMU we never, ever, ever, ever announce that a trial has been delayed, has been deprioritised, has been terminated or anything like that. While we have a legal responsibility to advise the FDA when such things occur, we can rely on no such "please explains" from the ASX. The ASX is far more concerned with a change in director interests notice being submitted 24 hours late to be worrying itself with minor details like a 4-year extension to a company's last kick on goal.

Now, by relentlessly avoiding announcing anything negative, our CEO can simply shrug her shoulders when asked about the $3b in evaporated market cap, and our Chair can continue to pay himself and his mates with the remaining market cap.

Thankfully we have a large number of shareholders who will happily spin a positive story about a 4-year extension - frankly they come up with far better stuff than we can - so you'll understand why we haven't provided a market update in respect of Azer-cel and can attend to your emails so quickly."